- Home
- Publications
- Publication Search
- Publication Details
Title
Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL ONCOLOGY
Volume -, Issue -, Pages -
Publisher
American Society of Clinical Oncology (ASCO)
Online
2022-01-26
DOI
10.1200/jco.21.02112
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
- (2021) Mary B. Daly et al. Journal of the National Comprehensive Cancer Network
- Therapeutic Implications of Germline Testing in Patients With Advanced Cancers
- (2021) Zsofia K. Stadler et al. JOURNAL OF CLINICAL ONCOLOGY
- PARP inhibitors in gastric cancer: beacon of hope
- (2021) Yali Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer
- (2021) Andrew N.J. Tutt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants
- (2020) Valentina Silvestri et al. JAMA Oncology
- The association of BRCA1 and BRCA2 mutations with prostate cancer risk, frequency, and mortality: A meta‐analysis
- (2019) Mok Oh et al. PROSTATE
- A decade of clinical development of PARP inhibitors in perspective
- (2019) J Mateo et al. ANNALS OF ONCOLOGY
- Prostate Cancer Risks for Male BRCA1 and BRCA2 Mutation Carriers: A Prospective Cohort Study
- (2019) Tommy Nyberg et al. EUROPEAN UROLOGY
- “I Am Uncertain About What My Uncertainty Even Is”: Men’s Uncertainty and Information Management of Their BRCA-Related Cancer Risks
- (2018) Emily A. Rauscher et al. Journal of Genetic Counseling
- Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
- (2017) Karoline B. Kuchenbaecker et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening†
- (2016) S. Paluch-Shimon et al. ANNALS OF ONCOLOGY
- Increased risk of male cancer and identification of a potential prostate cancer cluster region inBRCA2
- (2015) Henriette Roed Nielsen et al. ACTA ONCOLOGICA
- Breast-Cancer Risk in Families with Mutations in PALB2
- (2014) Antonis C. Antoniou et al. NEW ENGLAND JOURNAL OF MEDICINE
- Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study
- (2013) C M Phelan et al. BRITISH JOURNAL OF CANCER
- Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations
- (2011) A. Moran et al. Familial Cancer
- Germline BRCA Mutations Denote a Clinicopathologic Subset of Prostate Cancer
- (2010) D. J. Gallagher et al. CLINICAL CANCER RESEARCH
- Ascertainment in the sequential sampling of pedigrees
- (2010) C. Cannings et al. CLINICAL GENETICS
- Risk of breast cancer in male BRCA2 carriers
- (2010) D. G. R. Evans et al. JOURNAL OF MEDICAL GENETICS
- Associations of High-Grade Prostate Cancer with BRCA1 and BRCA2 Founder Mutations
- (2009) I. Agalliu et al. CLINICAL CANCER RESEARCH
- The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions
- (2008) A C Antoniou et al. BRITISH JOURNAL OF CANCER
- The Average Cumulative Risks of Breast and Ovarian Cancer for Carriers of Mutations in BRCA1 and BRCA2 Attending Genetic Counseling Units in Spain
- (2008) R. L. Milne et al. CLINICAL CANCER RESEARCH
- BRCAGermline Mutations in Jewish Patients With Pancreatic Adenocarcinoma
- (2008) Cristina R. Ferrone et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search